Cargando…
Chagas Disease Control—Many Approaches to Prospect
Autores principales: | Branquinha, Marta H., Sangenito, Leandro S., Oliveira, Simone S. C., d’Avila-Levy, Claudia M., Santos, André L. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459567/ https://www.ncbi.nlm.nih.gov/pubmed/37624333 http://dx.doi.org/10.3390/tropicalmed8080395 |
Ejemplares similares
-
Funding for Chagas Disease: A 10-Year (2009–2018) Survey
por: Sangenito, Leandro S., et al.
Publicado: (2020) -
Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
por: Sangenito, Leandro Stefano, et al.
Publicado: (2022) -
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
por: Branquinha, Marta H., et al.
Publicado: (2022) -
Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model
por: Sangenito, Leandro S., et al.
Publicado: (2014) -
Therapeutic Strategies against Leishmania and Trypanosoma
por: Santos, André L. S., et al.
Publicado: (2023)